Status: Not yet recruiting
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
This Phase 1 study will test the safety and immune response of the investigational vaccine DUVAX in healthy adults. Participants will be randomly assigned to receive either DUVAX or placebo by intramuscular injection. The study will evaluate how well the vaccine is tolerated and whether it produces antibodies against Alzheimer's disease-related proteins.
Participants needed: 24
Trial details
Phase: Phase 1Age: 40-65Biological sex: AllType: InterventionalSponsor: Nuravax, Inc.Updated: Oct 22, 2025Locations: 1
Eligibility criteria
Healthy males and non-pregnant, non-lactating females, 40-65 years old [+5]
Clinically significant medical or psychiatric illness that may affect safety or... [+7]